Form 4 for ALXO ALX ONCOLOGY HOLDINGS INC
Accepted 2024-08-16 00:00:00 ET · period of report 2024-08-14 · accession 0001415889-24-021471 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-16 | 2024-08-14 | ALXO | Lettmann Jason | CEO, Dir | F - Tax | $2.58 | -2,191 | 169.4K | -1% | -$5,653 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-14 | F | D | 2,191 | $2.58 | 169,429 | D | — | — |